• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The mechanism of dendritic cell-derived osteoclasts in the pathogenesis of arthritis.

Research Project

Project/Area Number 16K09915
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Collagenous pathology/Allergology
Research InstitutionUniversity of Occupational and Environmental Health, Japan

Principal Investigator

Hanami Kentaro  産業医科大学, 医学部, 助教 (50441853)

Co-Investigator(Kenkyū-buntansha) 久保 智史  産業医科大学, 医学部, 助教 (70461548)
Project Period (FY) 2016-10-21 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywords樹状細胞 / 破骨細胞 / 抗原提示能 / シグナル伝達
Outline of Final Research Achievements

We reported that human DCs can differentiate into (dendritic derived osteolast; DCOC) in the inflammatory lesion without being regulated by osteoblasts/osteocytes. DCOC possess not only the bone resorption ability but also the antigen-presenting function as DC. Actually, there were characteristic osteoclasts bearing costimulatory molecules in RA synovium, indicating that DCOC may play a pivotal role in the pathogenesis of RA by the maintenance of inflammation as well as joint destruction.

Academic Significance and Societal Importance of the Research Achievements

樹状細胞由来破骨細胞(dendritic derived osteolast; DCOC)は骨破壊に重要な役割を担うと共に、炎症性病態における免疫応答にも関与している可能性が考えられる。本研究では、関節リウマチ患者滑膜にDCOCが存在する事を示し、DCOCの分化機序の解明、DCOC機能と関節破壊・関節炎の関連を解明した事で、関節炎病態に対するより有効的な治療戦略を展開出来ると考えられ、医学的にも多大な意義を持つものと考える。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (7 results)

All 2019 2018 2017 2016 2015

All Journal Article (7 results) (of which Int'l Joint Research: 3 results,  Peer Reviewed: 7 results,  Open Access: 5 results,  Acknowledgement Compliant: 1 results)

  • [Journal Article] Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.2019

    • Author(s)
      Miyagawa I, Nakano K, Nakayamada S, Iwata S, Hanami K, Fukuyo S, Kubo S, Inoue Y, Ueno M, Tanaka Y.
    • Journal Title

      Int J Rheum Dis.

      Volume: 22(3) Issue: 3 Pages: 434-442

    • DOI

      10.1111/1756-185x.13387

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis.2018

    • Author(s)
      Ishikawa Y, Iwata S, Hanami K, Nawata A, Zhang M, Yamagata K, Hirata S, Sakata K, Todoroki Y, Nakano K, Nakayamada S, Satoh M, Tanaka Y.
    • Journal Title

      Arthritis Res Ther

      Volume: 20 Issue: 1 Pages: 240-240

    • DOI

      10.1186/s13075-018-1737-2

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; Adjusted with propensity score matching.2018

    • Author(s)
      Kubo S, Nakayamada S, Nakano K, Sawamukai N, Hirata S, Hanami K, Saito K1, Tanaka Y.
    • Journal Title

      Clin Immunol.

      Volume: 191 Pages: 67-74

    • DOI

      10.1016/j.clim.2018.03.018

    • Related Report
      2018 Annual Research Report 2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Pleurisy Caused by <i>Mycobacterium abscessus</i> in a Young Patient with Dermatomyositis: A Case Report and Brief Review of the Literature2018

    • Author(s)
      Noguchi S, Hanami K, Miyata H, Torii R, Shimabukuro I, Kubo S, Obata H, Yoshii C, Yatera K.
    • Journal Title

      Internal Medicine

      Volume: 57 Issue: 7 Pages: 997-1002

    • DOI

      10.2169/internalmedicine.9537-17

    • NAID

      130006602626

    • ISSN
      0918-2918, 1349-7235
    • Related Report
      2017 Research-status Report
    • Peer Reviewed
  • [Journal Article] Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients.2017

    • Author(s)
      Kubo S, Nakayamada S, Yoshikawa M, Miyazaki Y, Sakata K, Nakano K, Hanami K, Iwata S, Miyagawa I, Saito K, Tanaka Y.
    • Journal Title

      Arthritis Rheumatol.

      Volume: 69(10) Issue: 10 Pages: 2029-2037

    • DOI

      10.1002/art.40180

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.2016

    • Author(s)
      Hirata S, Li W, Kubo S, Fukuyo S, Mizuno Y, Hanami K, Sawamukai N, Yamaoka K, Saito K, Defranoux NA, Tanaka Y.
    • Journal Title

      Mod Rheumatol

      Volume: 26 Issue: 6 Pages: 850-856

    • DOI

      10.3109/14397595.2016.1153449

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.2015

    • Author(s)
      Kubo S, Nakayamada S, Nakano K, Hirata S, Fukuyo S, Miyagawa I, Hanami K, Saito K, Tanaka Y.
    • Journal Title

      Ann Rheum Dis.

      Volume: Aug 5 Issue: 7 Pages: 207784-207784

    • DOI

      10.1136/annrheumdis-2015-207784

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research

URL: 

Published: 2016-10-24   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi